In this double-blind , placebo-controlled trial , 120 asymptomatic Plasmodium falciparum parasite carriers were randomized to receive artemether-lumefantrine ( AL ) plus placebo or AL plus a single or repeated dose ( 200 g/kg ) of ivermectin ( AL-IVM1 and AL-IVM2 , respectively ) .